Your browser doesn't support javascript.
loading
The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China.
Yang, Rui-Xu; Zou, Zheng-Sheng; Zhong, Bi-Hui; Deng, Hong; He, Fang-Ping; Shi, Jun-Ping; Zhao, Cai-Yan; Mi, Yu-Qiang; Zhou, Yong-Jian; Di, Fu-Sheng; Zheng, Rui-Dan; Du, Qin; Shang, Jia; Popovic, Branko; Chen, JinJun; Fan, Jian-Gao.
Affiliation
  • Yang RX; Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai 200092, China.
  • Zou ZS; Department of Liver Disease, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • Zhong BH; Department of Gastroenterology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China.
  • Deng H; Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China.
  • He FP; Department of Gastroenterology II, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Regions, Urumqi 830011, China.
  • Shi JP; The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China.
  • Zhao CY; Department of Infectious Disease, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Mi YQ; Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.
  • Zhou YJ; Department of Gastroenterology and Hepatology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
  • Di FS; Department of Endocrinology and Metabolism, The Third Central Hospital of Tianjin, Tianjin 300170, China.
  • Zheng RD; Diagnosis and Treatment Center for Liver Diseases, Zhengxing Hospital, Zhangzhou 363000, China.
  • Du Q; Department of Gastroenterology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
  • Shang J; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou 450003, China.
  • Popovic B; Sanofi-Aventis Deutschland GmbH, Frankfurt 65929, Germany.
  • Chen J; Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address: chjj@smu.edu.cn.
  • Fan JG; Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai 200092, China. Electronic address: fanjiangao@xinhuamed.com.cn.
Hepatobiliary Pancreat Dis Int ; 20(5): 426-432, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34246549
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Metabolic Syndrome / Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Hepatobiliary Pancreat Dis Int Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Metabolic Syndrome / Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Hepatobiliary Pancreat Dis Int Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: China